Ocular Therapeutix Inc (OCUL)
8.71
+0.19
(+2.23%)
USD |
NASDAQ |
Nov 22, 14:47
Ocular Therapeutix Total Liabilities (Quarterly): 138.35M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 138.35M |
| June 30, 2024 | 139.40M |
| March 31, 2024 | 130.96M |
| December 31, 2023 | 160.93M |
| September 30, 2023 | 154.53M |
| June 30, 2023 | 119.47M |
| March 31, 2023 | 118.86M |
| December 31, 2022 | 113.91M |
| September 30, 2022 | 112.35M |
| June 30, 2022 | 107.27M |
| March 31, 2022 | 107.83M |
| December 31, 2021 | 116.89M |
| September 30, 2021 | 130.40M |
| June 30, 2021 | 150.46M |
| March 31, 2021 | 159.63M |
| December 31, 2020 | 185.77M |
| September 30, 2020 | 102.34M |
| June 30, 2020 | 101.92M |
| March 31, 2020 | 83.52M |
| December 31, 2019 | 82.37M |
| September 30, 2019 | 77.41M |
| June 30, 2019 | 81.48M |
| Date | Value |
|---|---|
| March 31, 2019 | 75.84M |
| December 31, 2018 | 37.17M |
| September 30, 2018 | 24.75M |
| June 30, 2018 | 24.73M |
| March 31, 2018 | 27.50M |
| December 31, 2017 | 29.28M |
| September 30, 2017 | 28.48M |
| June 30, 2017 | 31.65M |
| March 31, 2017 | 26.79M |
| December 31, 2016 | 22.93M |
| September 30, 2016 | 20.05M |
| June 30, 2016 | 19.45M |
| March 31, 2016 | 20.26M |
| December 31, 2015 | 20.72M |
| September 30, 2015 | 20.51M |
| June 30, 2015 | 20.36M |
| March 31, 2015 | 19.42M |
| December 31, 2014 | 19.50M |
| September 30, 2014 | 18.28M |
| June 30, 2014 | 93.41M |
| March 31, 2014 | 3.933M |
| December 31, 2013 | 78.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
82.37M
Minimum
Dec 2019
185.77M
Maximum
Dec 2020
125.86M
Average
119.17M
Median
Total Liabilities (Quarterly) Benchmarks
| 4D Molecular Therapeutics Inc | 51.08M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.37M |
| Shareholders Equity (Quarterly) | 352.02M |
| Debt to Equity Ratio | 0.1926 |
| Current Ratio | 13.01 |
| Net Debt Paydown Yield | -0.18% |